TipRanks
Hanall Biopharma Co., Ltd. (KR:009420)
:009420
South Korea Market

Hanall Biopharma Co., Ltd. (009420) Revenue

― Followers

Hanall Biopharma Co., Ltd. Revenue

Hanall Biopharma Co., Ltd. had a revenue of 44.28B in the quarter ending Jun 30, 2026, with 10.60%. This bring the company's revenue in the last twelve months to 162.66B, Decreased 2.26%. In the fiscal year ending Dec 31, 2025, Hanall Biopharma Co., Ltd. had annual revenue of 155.18B with 11.69% growth.
Revenue (ttm)
162.66B
Revenue Growth
8.38%
P/S Ratio
15.87
Revenue/Employee
₩492,649,283
Employees
315
Market Cap
₩2.46T

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
155.18B16.24B+11.69%
Dec 31, 2024
138.94B4.03B+2.99%
Dec 31, 2023
134.91B24.91B+22.65%
Dec 31, 2022
110.00B8.40B+8.27%
Dec 31, 2021
101.59B12.99B+14.66%
Dec 31, 2020
88.60B-19.85B-18.30%
Dec 31, 2019
108.45B16.61B+18.09%
Dec 31, 2018
91.84B7.61B+9.03%
Dec 31, 2017
84.23B――